PE Operating · Daily Portfolio Signal

Every Northwake PE engagement opens with one commitment: the operating partner wakes up to a hold-by-hold signal the next IC memo can be signed against, before the next market open. Not a quarterly portfolio review written eight weeks after quarter close. Not a snapshot of a company that has already moved. A boardroom-grade signal — one line per holding, per channel risk, per cash-conversion drift — reproduced from the underlying record and anchored to the 30/90/365-day baseline the portfolio has actually been running.

The signal is daily because the portfolio is daily. A freight lane that repriced two weeks ago on a single holding becomes a margin drag on the next LP note. A supplier whose terms shifted mid-quarter is the line the next operating committee defends — or it isn't, and the next IC catches it after the next quarter's close. The daily diagnostic is the channel that closes that gap, holding by holding, before the next market open.

The morning diagnostic is short by design. The operating partner does not have time to read a 40-page portfolio memo before the next market open. Northwake ships exactly three signal lines per holding: channel-risk drift, cash-conversion movement, and supplier-term exposure. Each is reproducible from a source record the operating team can paste into the next portfolio call. Each is anchored to the rolling baseline the diagnostic loop has been running since day one. Each carries the reg flag the next IC will eventually ask about.

Channel-risk drift is the first line. Every active channel — direct sales, partner channel, distributor overlay, the SKU mix the holding quietly rolled up under a re-priced freight contract — is re-anchored against the usage signal the diagnostic loop is already pulling. The drift lands tagged to the holding that pays for it, in the SKU codes and account IDs the operating team can paste into the next vendor call.

Cash-conversion movement is the second. DSO, DPO, and the cash conversion cycle are re-priced against the rolling baseline, holding by holding, refreshed against the same overnight cadence. The signal the next IC memo is signed against is the signal the diagnostic surfaces at market open — not the segment the prior quarterly retro baked into the slide.

Supplier-term exposure is the third. Freight, ledger, and SaaS spend re-priced against the holding's actual run-rate, not the peer panel the last dashboard aggregated. The drift lands in carrier names and SKU codes the operations team can paste into the next vendor review, renewal-ready, sourced from the public rate sheet and tagged to the contract that pays for it.

A traditional PE portfolio review is a quarterly retro: the data lands two weeks after quarter close, the slides are written by a junior who joined eight weeks ago, and the IC sees a snapshot of a company that has already moved. The Northwake cadence inverts that. The diagnostic loop runs overnight — ingest, diagnose, draft — and the operating partner reads the signal before the next market open. The IC sees the holding-by-holding line item, not the post-hoc narrative the last quarterly retro invented to defend it.

The cadence also collapses the portfolio cycle. A vendor that quietly repriced two weeks ago on a single holding shows up on Monday morning, tagged to the renewal the operating team has on the calendar. A channel mix that shifted at two portfolio companies in the same sector shows up on Tuesday, before the next IC call. The operating partner does not negotiate against the prior quarter. The operating partner negotiates against the morning read.

The cadence also changes the IC conversation. The operating partner does not arrive at the next quarterly with a stack of post-hoc slides asking the IC to ratify a margin drag the portfolio has already absorbed. The operating partner arrives with a hold-by-hold read, an LP-note draft the diagnostic has already produced, and the next renewal window the diagnostic has named. The diagnostic does the continuous, unglamorous work the IC has historically absorbed in a single two-day sit.

Every signal Northwake surfaces is reproducible from the underlying record. The audit trail the next LP walks is the same trail the diagnostic loop writes against from day one — no shared-model training, no shadow ledger, no retro-fitted IC memo. Records sit inside a single-tenant isolation envelope: signed, encrypted, regional placement set per engagement.

Nothing leaves the portfolio account to train a shared model, and no operator at Northwake pokes through without an explicit, traceable reason. For the regulated-spend overlay — supplier dispute, a sanction-adjacent read, a contract question that carries IC-grade weight — the senior review layer fires at the pressure point, audit-logged. The agents do the continuous, unglamorous work; the senior review layer gates the two moments where boardroom accountability is not delegable.

Day one: we scope the diagnostic against the portfolio — every active holding, every channel mix, every supplier-term overlay the operating team is already running — and you meet the operator who owns the engagement. There is no procurement cycle, no scoped RFP, no steering committee to align.

Day two — before the next market open — the first portfolio signal lands on the diagnostic. The first line per holding is the cash-conversion read, refreshed against the holding's open AR. The second is the channel-risk drift, tagged to the SKU codes that repriced in the last ninety days. The third is the supplier-term exposure, holding-by-holding. From the second day onward, that cadence is what the next LP note and the next IC memo are signed against.